Education
About Us
Working with TipRanks
Follow Us
Fuji Pharma Co., Ltd. (DE:FUP)
FRANKFURT:FUP
FUP Stock Chart & Stats
Day’s Range― - ―
52-Week Range€7.05 - €10.30
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€192.32M
Enterprise Value€57.38B
Total Cash (Recent Filing)€3.70B
Total Debt (Recent Filing)¥30.41B
Price to Earnings (P/E)9.8
Beta0.53
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-Date
Sep 29, 2025Dividend Yield3.59%
Share Statistics
EPS (TTM)0.07
Shares Outstanding24,863,600
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)0.70
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.40%
Mutual Funds
― Other Institutional Investors
95.97% Public Companies and
Individual Investors
FUP FAQ
What was Fuji Pharma Co., Ltd.’s price range in the past 12 months?
Fuji Pharma Co., Ltd. lowest stock price was €7.05 and its highest was €10.30 in the past 12 months.
What is Fuji Pharma Co., Ltd.’s market cap?
Fuji Pharma Co., Ltd.’s market cap is €192.32M.
When is Fuji Pharma Co., Ltd.’s upcoming earnings report date?
Fuji Pharma Co., Ltd.’s upcoming earnings report date is Aug 07, 2025 which is in 62 days.
How were Fuji Pharma Co., Ltd.’s earnings last quarter?
Fuji Pharma Co., Ltd. released its earnings results on May 08, 2025. The company reported €0.074 earnings per share for the quarter, beating the consensus estimate of N/A by €0.074.
Is Fuji Pharma Co., Ltd. overvalued?
According to Wall Street analysts Fuji Pharma Co., Ltd.’s price is currently Overvalued.
Does Fuji Pharma Co., Ltd. pay dividends?
Fuji Pharma Co., Ltd. pays a Annually dividend of €0.137 which represents an annual dividend yield of 3.59%. See more information on Fuji Pharma Co., Ltd. dividends here
What is Fuji Pharma Co., Ltd.’s EPS estimate?
Fuji Pharma Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fuji Pharma Co., Ltd. have?
Fuji Pharma Co., Ltd. has 24,863,600 shares outstanding.
What happened to Fuji Pharma Co., Ltd.’s price movement after its last earnings report?
Fuji Pharma Co., Ltd. reported an EPS of €0.074 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.205%.
Which hedge fund is a major shareholder of Fuji Pharma Co., Ltd.?
Currently, no hedge funds are holding shares in DE:FUP
Company Description
Fuji Pharma Co., Ltd.
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Technical Analysis
Torii Pharmaceutical Co
―
Towa Pharmaceutical Co
―
Mochida Pharmaceutical Co., Ltd.
―
KYORIN Pharmaceutical Co.,Ltd.
―
ASKA Pharmaceutical Holdings Co., Ltd.
―